- Home
- Biotechnology Industry
- Recombinant Protein Market and Forecasts, May 2013
Industries
- Biotechnology (165)
- Biopharmaceutical (133)
- Drug and Medication (83)
- Genomics (47)
- Pathology (46)
-
- Energy & Environment (42)
- Genetically Modified Organism, Gmo (40)
- Fruit and Vegetable (39)
- Agriculture (36)
- Biological Therapy (32)
- Dairy Products and Egg (30)
- Renewable Energy (26)
- Agrochemical (14)
- Blood Supply, Tissue Banking and Transplantation (14)
- Fish and Seafood (13)
- Livestock (13)
- Pharmaceutical (13)
- Drug Discovery and Development (12)
- Diagnostics (11)
- Food (10)
Top countries
- United States (292)
- India (117)
- World (79)
- China (72)
- Europe (57)
-
- Canada (34)
- Japan (27)
- Germany (27)
- Australia (27)
- South Korea (18)
- United Kingdom (17)
- Brazil (16)
- Africa (14)
- Malaysia (12)
- Pakistan (11)
- Thailand (10)
- Russian Federation (10)
- Spain (10)
- South Africa (9)
- France (9)
Publication dates
All regions
-
- Austria (5)
- Belgium (5)
- Bulgaria (2)
- Czech Republic (4)
- Denmark (2)
- Finland (6)
- France (9)
- Germany (27)
- Greece (2)
- Hungary (2)
- Ireland (6)
- Italy (7)
- Latvia (1)
- Lithuania (5)
- Luxembourg (1)
- Netherlands (8)
- Norway (8)
- Poland (7)
- Portugal (1)
- Romania (5)
- Russian Federation (10)
- Serbia and Montenegro (5)
- Slovenia (2)
- Spain (10)
- Sweden (5)
- Switzerland (4)
- Ukraine (1)
- United Kingdom (17)
-
- Australia (27)
- Austria (5)
- Belgium (5)
- Canada (34)
- Chile (1)
- Czech Republic (4)
- Denmark (2)
- Finland (6)
- France (9)
- Germany (27)
- Greece (2)
- Hungary (2)
- Ireland (6)
- Israel (5)
- Italy (7)
- Japan (27)
- Luxembourg (1)
- Mexico (6)
- Netherlands (8)
- New Zealand (1)
- Norway (8)
- Poland (7)
- Portugal (1)
- Slovenia (2)
- South Korea (18)
- Spain (10)
- Sweden (5)
- Switzerland (4)
- Turkey (2)
- United Kingdom (17)
- United States (292)
data types
- All
- Industry Data
- Company Data (664)
- Country Data (107)
Recombinant Protein Market and Forecasts, May 2013
You might be interested in: protein, vaccine, clinical trial, more »
industry reports
Recombinant Protein Industry (recombinant protein, protein)
- Industry report
- January 2012
- 19 pages
... recombinant proteins to be used as a pharmaceutical (fer-miralles et al., 2009). Global sales of biopharmaceuticals are estimated to account for us$70 80 billion today (walsh, 2010). Industrial enzymes (e ...
- Industries: Biopharmaceutical
Protein Market Brief (protein, recombinant protein)
- Industry report
- November 2011
- 13 pages
... Folded and biologically active recombinant proteins can be prepared. Such active protein particles can be further used for the isolation of pure proteins or as whole active protein particles in various ...
- Industries: Biopharmaceutical
Protein Sector (protein, recombinant protein) in Spain
- Industry report
- July 2011
- 6 pages
... Drugs to fulfill their increas- ing demand. Conclusions stability and solubility of recombinant proteins is a criti- cal issue at both production and post-production stages. For a biomedical use ...
- Industries: Biopharmaceutical
- Countries: Spain
Protein Market (protein, recombinant protein) in The United States
- Industry report
- April 2011
- 17 pages
... The global protein therapeutics market is approaching $100 billion in annual sales. Furthermore, the in vitro diagnostic market, which relies heavily on the use of recombinant proteins as analyte specific ...
- Industries: Biopharmaceutical
- Countries: United States
Protein Market (protein, recombinant protein) in China
- Industry report
- April 2012
- 9 pages
- by Research Paper
... From commercially available recom- binant sa (figure 7). Discussion over expression of recombinant proteins toxic to the host is often problematic, leading to either low production or insoluble ...
- Industries: Biopharmaceutical
- Countries: China
The Chinese Protein Sector Brief (protein, recombinant protein)
- Industry report
- August 2012
- 7 pages
- by Corporation
... The protein and host. Species-specific variations in codon usage are often cited as one of the major factors affecting protein expression, suggesting the effectiveness of codon optimization to suit a particular ...
- Industries: Biopharmaceutical
- Countries: China
Protein Market (protein, recombinant protein) in Uruguay
- Industry report
- February 2011
- 11 pages
... Not uncommon that overexpressed recombinant proteins fail to reach the correct conformation (folding) and un- dergo proteolytic degradation or associate with each other to form insoluble aggregates of non ...
- Industries: Biopharmaceutical
- Countries: Uruguay
The Chinese Protein Industry (protein, recombinant protein)
- Industry report
- July 2011
- 14 pages
- by Research Paper
... Low protein yield has been a persistent challenge in further development of transgenic plants as a practical recombinant protein production platform. In previous studies in an attempt to express h ...
- Industries: Biotechnology
- Countries: China
Protein Sector (protein, recombinant protein, enzyme) in Spain
- Industry report
- May 2012
- 11 pages
... Have arrived in which recombinant bacteria are to be engineered for the controlled packaging of therapeutic proteins as nanoparticulate materials (nanopills), for the ir extra- or intra ...
- Industries: Biopharmaceutical
- Countries: Spain
Protein Market (protein, recombinant protein) in The United States
- Industry report
- January 2011
- 5 pages
... Represented in this case by recombinant had-superfamily hydrolase from ehrlichia chaffeensis. Lanes are labelled as follows: m, molecular-weight standards; t, total protein; s, soluble fraction; ft, flowthrough ...
- Industries: Biopharmaceutical
- Countries: United States
» Read our Company Profiles
1 Companies for Recombinant ProteinAccessEd
AustraliaReportlinker.com © Copyright 2013. All rights reserved.
